Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 77,862
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12594240 | Artificial vitreous humor for the investigation of drugs and drug formulations | 🖼🧊📄§ | 2026-04-07 | 2043-04-11 | 0 | 31 |
| 12594243 | Pharmaceutical formulations | 🖼🧊📄§ | 2026-04-07 | 2043-11-03 | 0 | 31 |
| 12594246 | Formulations for enteric delivery of therapeutic agents | 🖼🧊📄§ | 2026-04-07 | 2042-10-03 | 0 | 31 |
| 12594247 | Edged cataplasm and manufacturing process | 🖼🧊📄§ | 2026-04-07 | 2043-02-07 | 0 | 31 |
| 12594250 | Prevention of accumulated tolerance to stimulant medication for the treatment of ADHD | 🖼🧊📄§ | 2026-04-07 | 2045-04-10 | 0 | 31 |
| 12594248 | Stress management in human subjects in need thereof | 🖼🧊📄§ | 2026-04-07 | 2041-01-13 | 0 | 31 |
| 12594253 | HIV inhibitors | 🖼🧊📄§ | 2026-04-07 | 2039-07-24 | 0 | 31 |
| 12594252 | Methods for treating inflammatory skin conditions | 🖼🧊📄§ | 2026-04-07 | 2042-06-20 | 0 | 31 |
| 12594258 | Inhibitors of MHC-I Nef downmodulation for treating HIV | 🖼🧊📄§ | 2026-04-07 | 2040-12-16 | 0 | 31 |
| 12594262 | CAI nanoemulsions | 🖼🧊📄§ | 2026-04-07 | 2040-12-18 | 0 | 31 |
| 12594264 | Modulators of alpha-synuclein proteolysis and associated methods of use | 🖼🧊📄§ | 2026-04-07 | 2043-09-18 | 0 | 31 |
| 12594263 | CBL inhibitors and compositions for expansion of immune cells | 🖼🧊📄§ | 2026-04-07 | 2040-09-23 | 0 | 31 |
| 12594260 | Topical formulations for infections | 🖼🧊📄§ | 2026-04-07 | 2044-06-28 | 0 | 31 |
| 12594265 | Methods and compositions for inhibition of STAT3 | 🖼🧊📄§ | 2026-04-07 | 2042-08-22 | 0 | 31 |
| 12594267 | Capsid inhibitors for the treatment of HIV | 🖼🧊📄§ | 2026-04-07 | 2044-02-27 | 0 | 31 |
| 12594273 | Intranasal DHE for the treatment of headache | 🖼🧊📄§ | 2026-04-07 | 2042-06-07 | 0 | 31 |
| 12594271 | Combination therapy for cancer | 🖼🧊📄§ | 2026-04-07 | 2040-11-05 | 0 | 31 |
| 12594280 | Antiviral compositions for treating the flu | 🖼🧊📄§ | 2026-04-07 | 2042-05-31 | 0 | 31 |
| 12594274 | Method for preparing a crystalline form of rabeximod | 🖼🧊📄§ | 2026-04-07 | 2041-06-10 | 0 | 31 |
| 12594281 | Pharmaceutical dosage forms and methods of use | 🖼🧊📄§ | 2026-04-07 | 2045-05-16 | 0 | 31 |
| 12594285 | Compositions and methods for protecting against airborne pathogens and irritants | 🖼🧊📄§ | 2026-04-07 | 2041-10-08 | 0 | 31 |
| 12594282 | Use of small molecule compounds in the treatment of diseases mediated by lung epithelial cell injury and/or vascular endothelial cell injury | 🖼🧊📄§ | 2026-04-07 | 2041-02-26 | 0 | 31 |
| 12594290 | IP and IP analogs dosage regimens for the treatment of ectopic calcifications | 🖼🧊📄§ | 2026-04-07 | 2045-02-27 | 0 | 31 |
| 12594286 | Immunodulating small molecules | 🖼🧊📄§ | 2026-04-07 | 2042-05-25 | 0 | 31 |
| 12594289 | Potentiation of antibiotic effect | 🖼🧊📄§ | 2026-04-07 | 2043-08-11 | 0 | 31 |
| 12594292 | Antiviral prodrugs, intermediate-and long-acting formulations and methods | 🖼🧊📄§ | 2026-04-07 | 2043-01-26 | 0 | 31 |
| 12594291 | Intratumoral alpha-emitter radiation and activation of cytoplasmatic sensors for intracellular pathogen | 🖼🧊📄§ | 2026-04-07 | 2039-10-31 | 0 | 31 |
| 12594296 | Methods for treatment or prevention of damage resulting from radiation, trauma or shock | 🖼🧊📄§ | 2026-04-07 | 2044-02-02 | 0 | 31 |
| 12594294 | Therapeutic and prophylactic agent for glioma, brain tumor malignancy marker, brain tumor prognostic marker, method for determining malignancy and prognosis of brain tumor and antibody inhibiting tumor proliferation | 🖼🧊📄§ | 2026-04-07 | 2039-12-27 | 0 | 31 |
| 12594297 | Composition comprising hyaluronic acid and pluronic for preventing or treating articular and cartilage injury | 🖼🧊📄§ | 2026-04-07 | 2040-08-03 | 0 | 31 |
| 12594301 | Compositions and methods for treatment of liquid cancers | 🖼🧊📄§ | 2026-04-07 | 2040-09-25 | 0 | 31 |
| 12594302 | Single domain antibodies and their use in cancer therapies | 🖼🧊📄§ | 2026-04-07 | 2041-05-20 | 0 | 31 |
| 12594299 | Photosynthetic cellular substances and methods of use thereof | 🖼🧊📄§ | 2026-04-07 | 2042-08-19 | 0 | 31 |
| 12594307 | Compositions and methods of using inducible signaling for tunable dynamics in microbial communities | 🖼🧊📄§ | 2026-04-07 | 2040-12-11 | 0 | 31 |
| 12594306 | Use of ENTPD3 for identification, isolation, and enhancing mature stem cell derived insulin-producing cells | 🖼🧊📄§ | 2026-04-07 | 2042-03-25 | 0 | 31 |
| 12594310 | Composition comprising lactic acid bacteria derived from green tea for improving liver function | 🖼🧊📄§ | 2026-04-07 | 2043-05-08 | 0 | 31 |
| 12594312 | Bacteriophage compositions for treating Pseudomonas infection | 🖼🧊📄§ | 2026-04-07 | 2041-04-27 | 0 | 31 |
| 12594311 | Lactobacillus plantarum PDG8 and use in treating cardiovascular diseases | 🖼🧊📄§ | 2026-04-07 | 2043-05-24 | 0 | 31 |
| 12594315 | Use of Liriodendron chinense (Hemsl.) Sarg. or extract thereof in the preparation of medicament for reducing serum uric acid level and preventing and treating uric acid nephropathy | 🖼🧊📄§ | 2026-04-07 | 2040-10-23 | 0 | 31 |
| 12594314 | Process and apparatus for production of a granular cannabinoid material essentially soluble in aqueous medium | 🖼🧊📄§ | 2026-04-07 | 2040-06-23 | 0 | 31 |
| 12594321 | Bispecific chimeric antigen receptor that binds CD19 and CD20, encoding nucleic acid molecules thereof and methods of use thereof to treat cancer | 🖼🧊📄§ | 2026-04-07 | 2043-12-05 | 0 | 31 |
| 12594319 | Pharmaceutical development | 🖼🧊📄§ | 2026-04-07 | 2040-07-28 | 0 | 31 |
| 12594318 | System and method for manufacturing a policosanol-rich granulated sugar cane juice product | 🖼🧊📄§ | 2026-04-07 | 2042-11-10 | 0 | 31 |
| 12594325 | Interleukin-18 variants and methods of use | 🖼🧊📄§ | 2026-04-07 | 2044-11-08 | 0 | 31 |
| 12594323 | Methods of reducing neuroinflammation | 🖼🧊📄§ | 2026-04-07 | 2043-04-13 | 0 | 31 |
| 12594327 | Compositions useful for treating GM1 gangliosidosis | 🖼🧊📄§ | 2026-04-07 | 2039-09-30 | 0 | 31 |
| 12594322 | Liquid composition comprising protein | 🖼🧊📄§ | 2026-04-07 | 2039-09-10 | 0 | 31 |
| 12594332 | Methods of treating psoriasis with secukinumab | 🖼🧊📄§ | 2026-04-07 | 2044-12-16 | 0 | 31 |
| 12594331 | Methods of treating psoriasis with secukinumab | 🖼🧊📄§ | 2026-04-07 | 2044-12-16 | 0 | 31 |
| 12594330 | Anti-opioid compounds and methods of making and using same | 🖼🧊📄§ | 2026-04-07 | 2040-06-04 | 0 | 31 |